Deadlines & milestones.

Compliance deadlines, implementation dates, and consultation windows extracted from upcoming EU, UK, Swiss and US health regulation.

2025

7 deadlines
26 MAY
Compliance Deadline

IVDR Class D/IVDD Devices - Application Deadline

Final deadline to submit applications to Notified Bodies for Class D IVDs and ALL IVDD-certified devices. Must have QMS implemented and application lodged to benefit from extended transition period...

High Medical Devices EC Medical Devices
16 JUN
Regulatory Event

UK Post-Market Surveillance Regulations

Enhanced PMS requirements come into force for ALL medical devices in Great Britain. Manufacturers must implement clearer, risk-proportionate surveillance systems with enhanced data collection, perf...

High Medical Devices UK MHRA
01 JUL
Regulatory Event

UK New Medical Device Regulation Implementation

MHRA's new UK-specific medical device regulations enter into force, replacing current system based on EU directives. Enhanced post-market surveillance, software updates regulation, and AI-enabled d...

High Medical Devices UK MHRA
01 OCT
Regulatory Deadline

Guidance: Route B substantial modification pilot

Clinical trials Route B substantial modifications pilot starts on 1 October 2025. Prepare for the implementation of new regulations from 28 April 2026.

High Pharmaceuticals UK MHRA

2026

23 deadlines
01 JAN
Enters into Force

HTA Regulation - Medical Devices

Joint Clinical Assessments extend to selected high-risk medical devices and in-vitro diagnostics

High Medical Devices European Commission
01 JAN
Regulatory Event

Germany DiGA Performance Reporting Mandatory

Digital health app (DiGA) manufacturers must implement continuous performance measurement and reporting (AbEM system) to BfArM. Results published in DiGA directory. Up to 20% of reimbursement price...

High Digital Health & AI BfArM DiGA Fast Track
26 JAN
Regulatory Event

Germany DiGA Success-Based Pricing Implementation

DiGA reimbursement model shifts to outcome-based pricing where up to 20% of price calculated based on demonstrated success. Manufacturers must provide evidence of positive healthcare effects. Strea...

Medium Digital Health & AI BfArM DiGA Fast Track
30 MAR
Regulatory Event

UK DORS Annual Registration Fee System

MHRA transitions from one-time device registration fees to annual category-based model. Manufacturers must update/verify registrations before March 30, 2026, then pay annual fees via DORS system wi...

Medium Medical Devices UK MHRA
01 APR
Regulatory Deadline

EU Pharmaceutical Package (Pharma Reform) - Adoption

Historic revision of EU pharmaceutical legislation expected to conclude trilogue negotiations. Major changes include: modified regulatory data protection periods (6+2 years base, up to 12 years wit...

High Pharmaceuticals EC Pharmaceutical Strategy
28 APR
Regulatory Event

UK Clinical Trials Reform

New streamlined Combined Review process for UK clinical trials begins. Single application for MHRA and REC approval, maximum 100-day review timeline, mandatory trial registration and results public...

High Clinical Trials UK Health Research Authority
15 MAY
Regulatory Event

EUDAMED Core Modules Become Mandatory

First phase of EUDAMED database becomes mandatory 6 months after Official Journal publication. All manufacturers must register as economic actors and register devices in UDI/Device module. National...

High Medical Devices EUDAMED
16 MAY
Compliance Deadline

France HDS Certification - New Standards Mandatory

All health data hosting providers must comply with updated HDS (Hébergeur de Données de Santé) certification standards. Digital health companies processing French patient data must use HDS-certifie...

High Health Data & Privacy ANS - French Digital Health Agency
22 JUL
Regulatory Deadline

Δήλωση Αποθεμάτων Φαρμάκων Ανθρώπινης Χρήσης

“Παρακαλούνται οι φαρμακαποθήκες όπως δηλώσουν τα αποθέματά τους την Τρίτη 21/07/2026 και ώρα 11:30πμ στην on-line ηλεκτρονική εφαρμογή «Δήλωση Αποθεμάτων

Medium Pharmaceuticals Greece EOF
06 NOV
Regulatory Deadline

Závery z výboru pre hodnotenie rizík liekov (PRAC) 8.–11.6.2026

Stručné zhrnutie záverov zo zasadania Výboru pre hodnotenie rizík liekov (PRAC), ktoré sa uskutočnilo 8.–11.6.2026. Plné znenie správy sa nachádza nawebovej stránke Európskej liekovej agentúry.

Medium Pharmaceuticals Slovakia SUKL